A New Era for Menopause Hormone Therapy

Today I want to talk about the black box warning that was on all estrogen products. If you don’t know yet, the warning is finally being removed after 23 years. And while I salute the decision, I have mixed feelings.

As a patient, someone who went through the nightmare of a difficult perimenopause and then menopause, I was ignored, dismissed, and under-treated for years. Not just in one country, but in every country I lived in. And now that the FDA has finally made this move, I have a lot to say.

When I finally got my first prescription for estrogen therapy, I thought the worst was behind me. I had fought hard for it, pushing past doctor after doctor who treated hormones like a last resort or a dangerous substance. I was told not to take estrogen past age 60, to use the smallest dose possible, and only for a short time, and only if my symptoms were “bad enough.” No one asked how I felt. No one wanted to discuss benefits. It was all fear, all the time.

Then I opened the medicine box.

Inside was the longest warning insert I’d ever seen, when fully unfolded it was taller than my husband, printed on both sides, packed with reasons why I probably shouldn’t take the medication at all. Stroke, heart attack, blood clots, cancer. Death. That was the message. It didn’t have a literal black box around it (like the US has on their products), but it didn’t need one. The intimidation was baked right in.

And it’s the same story across the globe. Whether the label says it out loud or not, hormone therapy has been treated like a threat, not a legitimate form of care.

So when the FDA announced it would remove the black-box warning from many estrogen-based therapies, I didn’t celebrate right away. This isn’t a win. It’s a long-overdue correction.

Jump to:

More Readings

What Is a Black-Box Warning, and Why Was It There?

If you’ve never heard of a “black-box warning,” here’s the deal: it’s the strongest warning the FDA can slap on a medication label. It’s a literal black box printed around a block of text that screams: This drug could kill you, so proceed with extreme caution. It’s meant to alert doctors and patients to serious or life-threatening risks. Think antidepressants (especially SSRIs and SNRIs), opioids, chemotherapy drugs etc. Things you don't mess around with.

So when estrogen therapy, something millions of women used to manage menopausal symptoms, was given a black-box warning in 2003, it sent a shockwave through the medical world. And through every woman sitting in a clinic asking for help.

The warning came after early results from the Women’s Health Initiative (WHI) study suggested that hormone therapy increased the risk of breast cancer, heart attack, stroke, and blood clots. The data were overgeneralized and misapplied, mostly drawn from older women taking oral, synthetic hormone combinations that aren’t commonly prescribed today. But the damage was done.

Almost overnight, all over the world, doctors stopped prescribing, women were taken off hormones, and the fear campaign began. For the next two decades, even mentioning hormone therapy in some offices was like bringing up cigarettes in a lung cancer ward. You were told: Nope. Too dangerous. Not worth the risk. Come back when you’re 65 and broken.

The black-box warning wasn’t just a label. It was a muzzle. It discouraged treatment, silenced curiosity, and trained generations of clinicians to avoid hormone therapy altogether. And now, after 23 years, that box is finally being pried open.

What’s Changing and What’s Staying

As of November 2025, the FDA has announced it will remove the black-box warning from most estrogen, progesterone and testosterone hormone therapy products prescribed to menopausal women. This includes transdermal options like gels, patches, and sprays, the forms many women prefer because they avoid the liver and are absorbed steadily.

The black-box warning was originally added in 2003, following results from the WHI that suggested increased risks of breast cancer, heart attack, stroke, and dementia in women using hormone therapy. But here’s the truth: those WHI findings were based largely on older women, many over 60, taking oral synthetic hormones, including a form of progestin that is no longer widely used. For decades, that data was misapplied to every woman, regardless of age, health status, or hormone type.

Now, the FDA has acknowledged that the science has changed. It is way overdue anyway. The truth is that when estrogen therapy is started before age 60 or within 10 years of menopause, the benefits, including protection for bone, heart, and possibly brain, can outweigh the risks.

So what stays? The black-box warning remains for systemic estrogen used without progesterone in women with a uterus, due to the known risk of endometrial cancer. The FDA is not removing all warnings, just the black-box, which is their most severe form. Other cautions and usage guidelines will still be part of the labeling.

Why It Matters for Women Like Me

I’ve lived in different countries. The message was always the same: hormones were dangerous, we should not take them, but let the body run its own course on menopause without help.

So yes, I take this change personally and I think there is a lot of work that the medical field will have to do now.

Because for me, hormone therapy wasn’t cosmetic. It was survival. It gave me back my brain. It gave me back the ability to sleep through the night without waking up in panic. It allowed me to be present in my relationships, to work, to create, to write. And yet, every time I used it, I felt like I was doing something wrong. Every refill felt like a little rebellion.

Now, finally, the message is shifting, from shame to science.

It’s About More Than Just Hot Flashes

For too long, menopause care has been reduced to: “just sweat it out.” But untreated menopause isn’t just inconvenient. It’s risky.

Estrogen decline impacts:

Bone health: increasing risk of osteoporosis and fractures.
Cardiovascular health: menopause is a major turning point in women’s heart risk.
Cognitive function: studies suggest estrogen may support brain health when started early.
Metabolic health: insulin resistance, weight gain, and lipid changes are all part of the picture.
Mental health: mood swings, anxiety, irritability, decision fatigue… sound familiar?

Hormone therapy isn’t a cure-all. But it’s a tool. And women deserve access to every tool science has to offer, without being scared off by outdated warnings.

Proceed, but Proceed Smartly

Let’s be clear: the removal of the black-box warning is a huge step, but it’s not the finish line.

This is not about pushing hormones on every woman. It’s about restoring access and informed choice.

Hormone therapy is not for everyone. It is not a wellness trend or a magic cure, and it should never be handed out like candy. Women with certain cancers, clotting disorders, or genetic risks need highly individualized care, and for some, HRT may not be the right choice at all. There’s still more research needed, particularly for breast cancer survivors and women with complex health histories. We can’t trade one form of medical neglect for another.

What we need now is education. Everywhere.

Most doctors still don't know how to treat menopause. Many never received formal training, even though over half the population will go through it. We are in 2025 and women are still being dismissed, gaslit, and misinformed. This isn’t a knowledge gap, this is a crisis. And it’s one that spans generations, borders, and specialties.

Some doctors are simply behind. Others are too lazy to update their knowledge. And some, let’s be honest, still think menopause care doesn’t matter. But the truth is this: every single specialty interacts with hormones, whether they realize it or not. Cardiology. Psychiatry. Rheumatology. Endocrinology. Internal medicine. Family care.

Every one of them should be fluent in hormone interactions, especially since so many drugs affect, and are affected by estrogen and progesterone levels. Right now, too many physicians have no clue how to adjust, support, or even recognize what's going on in the female body post-40.

Example: heart palpitations(you are sent to the cardiologist), mood swings( you are send to a psychiatrist), etc. While these investigations are great, it is still sad that the doctors are not able to connect the dots.

This is what I think should happen next. Removing the black-box warning is just the first swing at a very old, very rotten wall. Here’s what needs to follow:

Medical schools must add menopause and hormone therapy education to their core curriculum: not as an elective, not as a footnote, but as required training.
Continuing education must be mandatory for practicing physicians, especially those in women’s health, cardiology, psychiatry, and endocrinology.
All clinicians, not just gynecologists must be trained to recognize menopause symptoms and know how to talk about hormone therapy options with patients.
Patients must be empowered with evidence-based information so they can advocate for themselves and recognize when a provider is out of their depth. Women also need more education about their bodies, so they can recognize the signs of perimenopause.
All countries must review and revise their national guidance and stop copying outdated warnings from 2003. Science has moved forward. Policy should too. (Trust me, I lived in 3 different countries recently and they all have the same scary warnings on hormone products.)
Regulatory agencies need to stop weaponizing fear and start leaning into actual risk-benefit analysis, one that honors quality of life, not just pathology.
Pharmaceutical labels should be rewritten in plain language, not to sell, but to educate. We deserve clarity, not confusion.
And yes, every woman deserves a conversation. One that’s based on her individual history, her symptoms, and her future, not her age and a decades-old study.

We’ve had enough of this misery. Enough of being brushed off. Enough of being told “that’s just how it is.” Enough of watching women suffer needlessly while we pretend menopause is a lifestyle inconvenience.

This change, this FDA decision, is proof that the wall can crack. But the rest? That’s up to us.

We need louder voices. Braver doctors. Smarter systems. And a medical community that’s finally ready to do what it should’ve done all along: listen to women, treat us like full human beings, and care for us like we matter.

A Final Word

The removal of the black-box warning is not the end of the conversation. It’s the beginning of a better one.

It won’t undo the decades of fear, misinformation, and suffering. But it tells me someone’s finally listening. That maybe, just maybe, we’re entering an era where women’s health isn’t treated as an afterthought.

To the women who’ve been told to tough it out, to sit down and be quiet, I see you. To the doctors who’ve been afraid to prescribe, now you can lead with knowledge, not liability. And to the next generation of women entering perimenopause, may your path be easier than ours.

We fought for this change. Let’s make sure it leads to real, lasting care.